BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical hol

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $510.08, marking a +1.36% mov

- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new inte

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 10.96% on

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperfo

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third qu

The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQ

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exp

Amgen offers a diversified portfolio of established therapies across oncology and inflammation suppo

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $506.74, marking a -3.07% mov

Axsome Therapeutics is delivering explosive revenue growth as it scales its commercial portfolio for

Strong performance across the healthtech sector over the past two quarters has sparked renewed marke

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 6.27% on

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Vertex Pharmaceuticals is the leader in the cystic fibrosis market and has the intellectual property

Analysts raised targets for Vertex and Okta, while cutting targets for McDonald’s, AutoZone, Vaxcyte

UBS analyst Michael Yee maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the

Vertex Pharmaceuticals and Amgen recently posted strong clinical trial results for promising candida

Vertex Pharmaceuticals (VRTX) closed at $522.38 in the latest trading session, marking a +1.17% move

CRISPR Therapeutics is transitioning into a commercial-stage company with its pioneering gene-editin

VRTX announces positive AMPLIFIED data for inaxaplin, while completing AMPLITUDE enrollment and targ

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Tuesday reported data from its Phase 2b AMPLIFI

Vertex Pharmaceuticals reported positive Phase 2b data for inaxaplin in patients with APOL1-mediated

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhil

Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-mediated kidney disease (AMKD) and modest

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $508.34, signifying a -1.55% m

Nykredit A S purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) i

Baird Financial Group Inc. decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (

Engineers Gate Manager LP lowered its position in shares of Vertex Pharmaceuticals Incorporated (NAS

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.61% on

Morgan Stanley analyst Terence Flynn reinstates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overw

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.32% on

CNBC's Halftime Report Final Trades: Sechan picked ServiceNow (NYSE: NOW), Lebenthal chose Verte

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.35% on

Truist Securities analyst Danielle Brill maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Bu

Barclays analyst Eliana Merle maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight an

TD Cowen analyst Phil Nadeau maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises

Cantor Fitzgerald analyst Carter Gould maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Over

Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2026 sales outlook from $12.950 billion-$13.100 billio

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.73 per share which met the an

U.S. stock futures up, focus on earnings from Tyson Foods, Marriott, Universal Logistics, Williams C

CNN Money Fear & Greed index improved while remaining in 'Fear' zone on Friday. Amazon u

Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refin

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 7.55% on a

The Halftime Report Final Trades featured stock picks from Bryn Talkington, Jim Lebenthal, Liz Young

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) rose in pre-market trading after being acquired by Vert

U.S. stocks sank Monday as an Iranian drone attack on a UAE petroleum site sent Brent above $114, go